Corporate News     25-Sep-09
US District Court denies Wyeth's motion for temporary restraining order
On 24 September 2009
On 24 September 2009, the US District Court for the District of Columbia denied Wyeth Pharmaceutical's motion for a Temporary Restraining Order (TRO). Wyeth's request for TRO was filed in connection with its lawsuit against the US FDA challenging the US FDA approval of Orchid's ANDA for its generic products, Piperacillin and Tazobactam for Injections. The Court rejected Wyeth's requests and denied the TRO. In its Memorandum Opinion and Order, the Court found that 'Wyeth has failed to demonstrate a likelihood of success on the merits' of its claim that the US FDA's approval of Orchid's ANDA violated applicable US statutes.

Orchid is pleased with this result and will continue to protect its approved ANDAs for its Piperacillin and Tazobactam for Injections and also continue to supply the products to its distribution partner, Apotex Corp., for marketing and distribution in the US.

The company made this announcement during the trading hours today, 25 September 2009.

Previous News
  Pharmaceuticals
 ( Sector Trends - Sector 30-Jun-24   10:57 )
  Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
 ( Hot Pursuit - 29-Jun-24   10:08 )
  Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
 ( Corporate News - 28-Jun-24   19:23 )
  Sensex up 273 pts; IT shares outperforms
 ( Market Commentary - Mid-Session 06-Jun-24   14:42 )
  Orchid Pharma receives DCGI approval for Enmetazobactam
 ( Corporate News - 06-Jun-24   13:06 )
  Orchid Pharma gains on DCGI nod for new antibiotic drug combination
 ( Hot Pursuit - 06-Jun-24   12:38 )
  Pharmaceuticals
 ( Sector Trends - Sector 31-May-24   10:53 )
  Market ends with flat line, benchmarks hit fresh life high, media shares rally
 ( Market Commentary - Quick Review 24-May-24   15:41 )
  Orchid Pharma slides as PAT slumps 49% YoY in Q4 FY24
 ( Hot Pursuit - 24-May-24   12:56 )
  Orchid Pharma consolidated net profit declines 44.27% in the March 2024 quarter
 ( Results - Announcements 24-May-24   07:34 )
  Orchid Pharma to conduct board meeting
 ( Corporate News - 17-May-24   14:12 )
Other Stories
  Gujarat Toolroom to conduct EGM
  08-Jul-24   19:53
  Macro Intl. to conduct AGM
  08-Jul-24   19:52
  Ecoboard Industries schedules AGM
  08-Jul-24   19:52
  Eraaya Lifespaces schedules EGM
  08-Jul-24   19:52
  Binny to convene EGM
  08-Jul-24   19:52
  ICRA upgrades long term rating on bank facilities of Keystone Realtors
  08-Jul-24   19:17
  Sadbhav Engineering schedules EGM
  08-Jul-24   19:08
  Board of Va Tech Wabag approves divestment of Wabag Romania
  08-Jul-24   19:08
  Global Capital Markets to announce Quarterly Result
  08-Jul-24   19:07
  Motherson Sumi Wiring India schedules board meeting
  08-Jul-24   19:07
Back Top